News and Trends 22 Sep 2022 Research identifies new treatment target for CNS injury and neurological disease …research started out exploring DNA damage pathways activated following nerve injury. However, the same molecular factors feature in pathways are seen in neurodegenerative diseases, and a full understanding of these… September 22, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2022 EditForce creates U-to-C RNA-editing technology …or RNA sequence cause a variety of diseases. Treatment of these diseases requires single base-editing technology of repairing genomic or RNA mutations to bring the sequences back on the normal… October 18, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2019 Artificial Intelligence Detects Juvenile Arthritis in the Blood …unpick complex inflammatory diseases in other ways. One way is screening the genome for particular genes linked to these inflammatory diseases, and another is characterizing gut bacteria in the human… March 13, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2017 The Next Generation of Genetic Medicine: A Review of Epigenetics …diseases, but their use as a monotherapy has not been satisfactory.” The efficacy of these drugs has been marred by individual sensitivities to them that are difficult to untangle such… September 5, 2017 - 9 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2018 Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’ Altheia Science, based in Milan, has raised €17M to fund the development of gene therapies for autoimmune diseases with the remarkable potential to be curative. “The success of our fundraising… December 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 12 May 2023 Cell and gene therapy company NewBiologix exits stealth with $50M …experience in biotech and cell line development to the new entity. “Our mission is to help biopharmaceutical companies treat some of the most devastating diseases by providing them with innovative… May 12, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 15 May 2019 The Missing Piece in the Microbiome Field …beyond just cancer immunotherapy to many other diseases, and potentially even to neurodegenerative diseases, which also have an inflammatory component.” The intersection of cancer and the microbiome has attracted multiple… May 15, 2019 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2018 New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s Syndesi Therapeutics has been formed by UCB and a group of investors, including Novo Seeds and V-Bio to develop a group of compounds for cognitive disorders caused by diseases like… February 1, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 3 Mar 2020 How Immunotherapy Could Stop and Prevent Type 1 Diabetes …its potential to treat all sorts of diseases where the immune system is involved, including cancer and neurodegenerative conditions. As autoimmune diseases are directly caused by the immune system, immunotherapies… March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 17 Aug 2021 Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology …therapies for a range of conditions, including respiratory, liver, and infectious diseases. The company’s €2.7B ($3.2B) buyout, announced by Sanofi earlier this month, seems a tacit acknowledgment of the potential… August 17, 2021 - 5 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Oct 2025 Seven of the top biotech companies to know about in South San Francisco …solid tumors, as well as other immune-mediated diseases. By studying patient immune responses against cancer, it aims to discover the best immunogenic targets that can be generalized for multiple tumor… October 21, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2018 Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA Galapagos and ProQR will work together to target fibrosis using a technology to treat genetic diseases without permanent changes to the DNA. A new research collaboration between two biotech companies… January 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email